Alisauskas, R M <br/><br/>
Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice.  [electronic resource] 

 -  International journal of cancer  Jan 1997 
 - 323-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0215(19970127)70:3<323::aid-ijc13>3.0.co;2-g  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Marrow--drug effects<br/>Colony-Forming Units Assay<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology<br/>Growth Inhibitors--pharmacology<br/>Hematopoiesis--drug effects<br/>Interleukin-1--pharmacology<br/>Leukocyte Count--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Oligopeptides--pharmacology<br/>Pyrrolidonecarboxylic Acid--analogs & derivatives<br/>Radioimmunotherapy--adverse effects<br/>Time Factors